Email this article Fabry’s disease: Neurological disorders
- Authors: Damulin IV1
-
Affiliations:
- Issue: Vol 88, No 8 (2016)
- Pages: 111-114
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/32112
- DOI: https://doi.org/10.17116/terarkh2016888111-114
- ID: 32112
Cite item
Full Text
Abstract
The paper considers the pathogenesis and clinical features of Fabry’s disease. It is stressed that along with cardiovascular system damage and kidney injury, there are peripheral and central nervous system lesions in this disease. In Fabry’s disease, great attention is paid to cerebrovascular diseases that frequently give rise to disability. Peripheral neuropathy is mainly due to involvement of minor fibers and autonomic disorders. Signs that allow this disease to be diagnosed are given.
Keywords
References
- Federico A. Fabry’s disease and cerebrovascular disorders. Neurol Sci. 2002;23:47-48.
- Peters FPJ, Vermeulen A, Kho TL. Anderson-Fabry’s disease: alfa-galactosidase deficiency. Lancet. 2001;357:138-140.
- Brady RO, Gal AE, Bradley RM et al. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. New Engl J Med. 1967;276:1163-1167.
- Kolodny EH, Pastores GM. Anderson-Fabry disease: extrarenal, neurologic manifestations. J Am Soc Nephrol. 2002;13:S150-S153.
- Toyooka K. Fabry disease. Curr Opin Neurol. 2011;24:463-468.
- Bishop DF, Calhoun DH, Bernstein HS et al. Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci USA. 1986;83:4859-4863.
- Kornreich., Desnick RJ, Bishop DF. Nucleotide sequence of human alpha-galactosidase A gene. Nucleic Acids Res. 1989;17:3301-3302.
- Ginsberg L, Valentine A, Mehta A. Fabry disease. Pract Neurol. 2005;5:110-1103.
- Mohanraj R, Leach JP, Broome JC, Smith DF. Neurological presentation of Fabry’s disease in a 52 year old man. J Neurol Neurosurg Psychiatry. 2002;73:340-342.
- Germain DP. Fabry disease. Orphan J Rare Dis. 2010;5:30.
- Fellgiebel A, Muller MJ, Ginsberg L. CNS manifestations of Fabry’s disease. Lancet Neurol. 2006;5:791-795.
- Аверочкин А.И., Мозолевский Ю.В., Штульман Д.Р. Заболевания периферической нервной системы. В кн.: Болезни нервной системы. Руководство для врачей. Под ред. Яхно Н.Н., Штульмана Д.Р. Т.1. Гл.6. М.: Медицина; 2001.
- Simoncini C, Orsucci D, Gori S et al. Fabry disease with atypical neurological presentation: report of a case. The Neurologist. 2012;18:413-414.
- Lehmann HC, Hengge UR, Alswede L et al. A 32-year-old man with relapsing-progressive brainstem symptoms. Lancet Neurol. 2006;5(1):97-102.
- Moore DF, Kaneski CR, Askari H, Schiffmann R. The cerebral vasculopathy of Fabry disease. J Neurol Sci. 2007;257:258-263.
- Fancellu L, Deiana GA, Sechi GP. Neuroimaging leads to recognition of previously undiagnosed Fabry disease. Neurology. 2010;75:e28.
- Pruss S, Bohner G, Zschenderlein R. Paroxysmal vertigo as the presenting symptom of Fabry disease. Neurology. 2006;66:249.
- Kaneski CR, Moore DF, Ries M et al. Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease. Neurology. 2006;67:2045-2047.
- Chowdhury MMU, Holt PJA. Pain in Anderson-Fabry’s disease. The Lancet. 2001;357(9259):887.
- Buechner S, De Cristofaro MTR, Ramat S, Borsini W. Parkinsonism and Anderson Fabry’s disease: a case report. Mov Disord. 2006;21(1):103-119.
- Yoshikawa H, Ogawa I. Clinical diagnosis of Fabry disease. Whorl-like corneal opacity. Neurology. 2003;60:1048.
- Глыбочко П.В., Мухин Н.А., Свистунов А.А. и соавт. Морфологическая верификация почечного поражения как обязательный этап диагностики болезни Фабри. Терапевтический архив. 2014;86(12):31-34.
- Фомин В.В., Пулин А.А., Аксенова О.А. и др. Тяжелое поражение подоцитов, выявленное при электронной микроскопии почечного биоптата, у пациента с болезнью Фабри без выраженных изменений мочи и почечной недостаточности. Клиническая нефрология. 2012;1:55-58.
Supplementary files
